<\/p>\n
Ondem Injeksjon<\/strong> inneholder ondansetron 2 mg\/ml<\/strong> in 2 ml ampoules (4 mg total) — a selective serotonin 5-HT3 receptor antagonist<\/strong> used in hospitals to prevent and treat kjemoterapi-indusert<\/strong>, str\u00e5lebehandlingsindusert<\/strong>, og post-operative nausea and vomiting (PONV)<\/strong>. Administered by a healthcare professional intravenously (slow push or short infusion) or intramuscularly. Onset within 5–10 minutes IV. Manufactured by Alkem Laboratories — the generic equivalent of Zofran injection. FDA single-dose cap 16 mg IV<\/strong> due to QT signal at higher doses.<\/p>\n<\/div>\n \ud83d\udce6 Hver ordre er dekket av v\u00e5r Reshipment Assurance Policy<\/strong><\/a> \u2014 hvis pakken din ikke ankommer innen 20 virkedager, sender vi ny.<\/p>\n V\u00e5re generiske legemidler kommer fra WHO-GMP-sertifiserte produsenter og sendes over hele verden i diskret, n\u00f8ytral emballasje \u2014 ingen legemiddelnavn p\u00e5 utsiden av pakken. Kortbetalinger h\u00e5ndteres av en regulert betalingsbehandler (kontoutskrifter viser en regulert kortbetalingsprosessor \u2014 aldri \u201cMedsBase\u201d eller noe legemiddelnavn). Krypto og SEPA bankoverf\u00f8rsel godtas ogs\u00e5. Hver ordre er dekket av v\u00e5r Reshipment Assurance Policy.<\/p>\n Ondem Injection is supplied from a WHO-GMP-sertifisert produsent<\/strong>. Hver ordre sendes diskret over hele verden og er dekket av v\u00e5r Reshipment Assurance Policy<\/a> — if it does not arrive within 20 business days, we reship at no cost. Ondem Injection is the global standard parenteral 5-HT3 antagonist for inpatient antiemesis. Alkem is one of India’s largest WHO-GMP injectable manufacturers and the formulation is bioequivalent to the reference brand.<\/p>\n Chemotherapy, radiation, and surgical stress damage gut enterochromaffin cells, releasing massive amounts of serotonin (5-HT)<\/strong>. The serotonin binds 5-HT3 receptors on vagal afferents and on the chemoreceptor trigger zone (area postrema), generating the strongest known oral\/intestinal emetic stimulus. Ondansetron is a highly selective antagonist at the 5-HT3 receptor — it interrupts this signal at both peripheral and central sites without affecting D2, H1, muscarinic, or alpha-adrenergic receptors. The clean receptor profile explains the absence of sedation, extrapyramidal reactions, and anticholinergic side effects that limit older antiemetics like prochlorperazine and metoclopramide.<\/p>\nHvorfor bestille fra MedsBase<\/h3>\n
Hvorfor bestille fra MedsBase<\/h3>\n
Mekanisme for virkning<\/h2>\n
Indikasjoner<\/h2>\n
\n
Dose<\/h2>\n